2 results
Approved WMOCompleted
To compare the effect of semaglutide 1.0 mg once-weekly versus exenatide extended release (ER) 2.0 mg once-weekly on glycaemic control after 56 weeks of treatment.
Approved WMOCompleted
The objective of the Feeling Hot 1 study is to determine the change in penile skin temperature regarding the temperature increase and sensor response time during visually aroused erections when considering environmental influences of overnight…